Larvol Delta - AiViva-Biopharma-Completes-Phase-12-Clinical-Trial-of-AIV001-Administration-in-Patients-with-Nonmelanoma-Skin-Cancer

axitinib intradermal (AIV001) - AiViva BioPharma

https://www.globenewswire.com/news-release/2023/12/11/2793822/0/en/AiViva-Biopharma-Completes-Phase-1-2-Clinical-Trial-of-AIV001-Administration-in-Patients-with-Nonmelanoma-Skin-Cancer.html

Dec 11, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next